Home
Board Member Login
Advertising
Useful Links
Contact Us
Search
SEARCH AATOD
About Us
Organizational History
Overview of AATOD Activities
Patient Success Stories
Board of Directors
Member Center
Becoming an AATOD Member
Canon of Ethics
Membership Application
Membership Brochure
National Conference
2013 AATOD Conference – Philadelphia
2012 AATOD Conference – Las Vegas
2010 AATOD Conference – Chicago
2009 AATOD Conference – New York
2007 AATOD Conference – San Diego
2006 AATOD Conference – Atlanta
2004 AATOD Conference – Orlando
Photo Gallery – 2012 Conference
Projects/Educational Training
Preparing for EHRs and Healthcare reform for Opioid Treatment Providers
Hepatitis C
Determining the Prevalence of Prescription Opioid Use among Admissions to Opioid Treatment Programs
Methadone Treatment in the Criminal Justice
PCSS-M Project (Methadone Mentoring)
Resources
Frequently Asked Questions
Q&A
Glossary
Additional Education on Opioid Dependence
Publications & DVD’s
Policies
Policy Statements
End of Year Reports
Fact Sheets
Legislation
End of Year Reports
Coming Soon!
Policies
Policy Statements
AATOD Guidelines for Guest Medication
AATOD Guidelines for Using Naltrexone (Vivitrol) in OTPs
AATOD’s Five-Year Plan
AATOD’s Response to SAMHSA’s Federal Register Notice of May 16, 2013 in Updating the Accreditation Guidelines for OTPs
AATOD’s Response to SAMHSA’s Federal Register Notice of May 16, 2013 in Updating the Accreditation Guidelines for OTPs (Text Version)
Challenges and Opportunities (July 2012)
Guidance to OTPs Concerning the Use of Prescription Monitoring Program (PMP) Databases
Medication-Assisted Treatment for Opioid Addiction: Challenges and Solutions – June 2011
Washington State Prescription Monitoring Program – Notice to Patient of Evergreen Treatment Services
End of Year Reports
Fact Sheets
Legislation
Days Until
AATOD 2013 Conference
